Top Markets
#1 Status Status +18.91%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#3 GoPlus Security GoPlus Security +18.45%
#4 Wrapped NXM Wrapped NXM +15.13%
#5 Ontology Gas Ontology Gas +11.65%
#6 DMT-NAT DMT-NAT +8.98%
#7 Pons Pons +8.13%
#8 Provenance Blockchain Provenance Blockchain +7.18%
#9 Nesa Nesa +7.18%
#10 Janction Janction +7.01%
Coin of the day
Status Status
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Classifica tra le azioni #34063
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Prezzo delle azioni
$0.223
Ultima sincronizzazione: 2026-08-14
Capitalizzazione di mercato
$6.32M
Variazione (1 giorno)
1.64%
Variazione (1 anno)
-
Paese
US
Scambia Curanex Pharmaceuticals Inc Common Stock (CURX)

Categoria

Healthcare
Rapporto P/S per Curanex Pharmaceuticals Inc Common Stock (CURX)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Curanex Pharmaceuticals Inc Common Stock, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Curanex Pharmaceuticals Inc Common Stock da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE